Emerging Cellular Therapies
joint with Precision Genome Engineering
Scientific Organizers: Michel Sadelain, Aude G. Chapuis and Justin Eyquem
Date: February 13 - 17, 2022
|InPerson Location: Fairmont Chateau Whistler, Whistler, BC, Canada|
|Meeting is available as a Livestream, click register button below for more details|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
This multidisciplinary conference will focus on integrating emerging technologies and immunobiology to advance the genetic engineering of immune cells for the treatment of cancer and other pathologies. Main themes include strategies to identify novel immune targets, enhance the function of synthetic and natural receptors for antigen, and genetically engineer and edit T cells and their precursors. The conference will preeminently feature elucidating mechanisms of resistance to cell-based immunotherapies, including the roles of T cell differentiation, signaling and costimultory pathways and epigenetic profiles, as well as the mechanisms that lead to antigen escape in the context of the tumor microenvironment. The emergence of novel, alternative engineered cell types, including natural killer cells and pluripotent stem cell-derived immune cells, and their potential to overcome current barriers to immunotherapy, will also be examined. Overall, this meeting will offer a close examination of the fundamental mechanisms that determine the success of cell-based immunotherapies.
Global Health Travel Award Deadline: January 24 2022 details
Scholarship Deadline: November 2 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.